Enzymotec’s infant nutrition ingredients yield positive results in clinical trials
date:Sep 13, 2012
Enzymotec has announced that clinical trials for its lipid-based ingredient line for infant nutrition yielded positive results. These large-scale clinical research trials were conducted on newborn term infants in several institutes globally.

The clinical trial plan is a part of the company's strategy to develop and market its products, which mimic the vital lipids found in mother's milk, such as triglyceride, phospholipids and long-chain polyunsaturated fatty acids (LCPUFA).

Enzymotec Infant N
1/3 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/14 19:58